awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39010100-09227BA3-7679-4AF5-8B7F-4734EC5E1E23
Q39010100-09227BA3-7679-4AF5-8B7F-4734EC5E1E23
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39010100-09227BA3-7679-4AF5-8B7F-4734EC5E1E23
Rapamycin combined with celecoxib enhanced antitumor effects of mono treatment on chronic myelogenous leukemia cells through downregulating mTOR pathway.
P2860
Q39010100-09227BA3-7679-4AF5-8B7F-4734EC5E1E23
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39010100-09227BA3-7679-4AF5-8B7F-4734EC5E1E23
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
50e071b6c9428d53d64f81aa9005f5084683bc81
P2860
3-phosphoinositide-dependent protein kinase-1/Akt signaling represents a major cyclooxygenase-2-independent target for celecoxib in prostate cancer cells.